NinePointTwo Capital
- SEC CIK
- 0001824516
- Latest filing
- Feb 14, 2024
DNLI holding history
Denali Therapeutics Inc. in every 13F filed by NinePointTwo Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNLI overviewAll 13F holders of DNLIFull Q4 2023 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q3 2022